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ABSTRACT
In eukaryotes, it is generally assumed that transla-
tion initiation occurs at the AUG codon closest to
the messenger RNA 50 cap. However, in certain
cases, initiation can occur at codons differing from
AUG by a single nucleotide, especially the codons
CUG, UUG, GUG, ACG, AUA and AUU. While
non-AUG initiation has been experimentally verified
for a handful of human genes, the full extent to
which this phenomenon is utilized—both for
increased coding capacity and potentially also for
novel regulatory mechanisms—remains unclear. To
address this issue, and hence to improve the quality
of existing coding sequence annotations, we de-
veloped a methodology based on phylogenetic
analysis of predicted 50 untranslated regions from
orthologous genes. We use evolutionary signatures
of protein-coding sequences as an indicator of
translation initiation upstream of annotated coding
sequences. Our search identified novel conserved
potential non-AUG-initiated N-terminal extensions
in 42 human genes including VANGL2, FGFR1,
KCNN4, TRPV6, HDGF, CITED2, EIF4G3 and NTF3,
and also affirmed the conservation of known
non-AUG-initiated extensions in 17 other genes. In
several instances, we have been able to obtain in-
dependent experimental evidence of the expression
of non-AUG-initiated products from the previously
published literature and ribosome profiling data.
INTRODUCTION
Translation initiation is the only step during protein bio-
synthesis where an incoming aminoacyl tRNA is bound
directly in the ribosomal P-site (1,2). There is a greater
ﬂexibility for mismatches in the codon:anticodon duplex
in the P-site (3,4) in comparison with the A-site where,
in contrast, proper geometry of messenger RNA
(mRNA):tRNA interactions is strictly monitored by the
decoding center for the ﬁrst two positions of a codon (5).
As a result, initiator Met-tRNAi can be incorporated into
the ribosome at a wider range of codons than in the case of
elongator Met-tRNA whose incorporation is strictly
limited to AUG codons. Such a ﬂexible usage of initiation
codons by Met-tRNAi requires additional control mech-
anisms for discrimination between potential start sites.
These control mechanisms differ between eukaryotes
and bacteria. In fact, the initiation step represents the
biggest mechanistic difference in the process of protein
biosynthesis between organisms from different domains
of life. In bacteria, with a single notable exception of
psyllid endosymbiont Carsonella (6), the small subunit of
the ribosome binds the mRNA a short distance upstream
of the initiation codon through interaction between the
30-end of the 16S rRNA and a complementary sequence,
termed Shine–Dalgarno (7). In contrast, in eukaryotes, the
scanning model for the initiation of translation postulates
that the small ribosomal subunit, in complex with initi-
ation factors and Met-tRNAi, binds ﬁrst to the 50 cap.
Then it scans 50–30 until it ﬁnds a suitable initiator
codon (8). Exceptions include internal ribosome entry
sites, shunting and reinitiation mechanisms, see references
(9) and (10) for invigorating discussion of contrasting
viewpoints. During scanning, the efﬁciency of initiation
is dependent on the nucleotide context surrounding the
initiator codon with the optimal context being known as
the Kozak motif (11).
The initiation context—comprising the 6nt before and
the 1nt immediately following a potential initiation
codon—has signiﬁcant inﬂuence on the recognition
of that codon as an initiation site, through as yet
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of eIF1 (12,13). The optimal context in mammals is
GCCRCCAUGG (14) with the identity of the underlined
nucleotides in the  3 and+4 positions (relative to the ‘A’
of the AUG) being the most important. An ‘A’ in the  3
position is preferred over a ‘G’ and a purine in that
position is more important than a ‘G’ in the+4 position
(15). The identity of the nucleotides in the other positions
plays an important role only when there is no purine in
position  3 and no ‘G’ in position+4 (15).
Although relatively rare, initiation of translation of eu-
karyotic mRNAs can occur at non-AUG codons that
differ from AUG at a single nucleotide position.
Initiation on the nine possible such codons occurs with a
varying degree of efﬁciency that is partially taxon depend-
ent. For example, in mammals and plants CUG appears to
be the most efﬁcient non-AUG initiation codon, while
AAG and AGG are the least efﬁcient (16). For initiation
at non-AUG codons, the presence of a good Kozak
context is crucial (17–19). The rules for the most favorable
context are believed to be identical to those for an AUG
codon. In addition, a strong RNA secondary structure
starting  15nt downstream of the initiation site signiﬁ-
cantly increases the efﬁciency of initiation at non-AUG
codons (20).
In mammals, at least 38 mRNAs from 23 genes have
been reported to have or else have annotated non-AUG
initiation codons in GenBank (21). In most cases, the
non-AUG initiation provides an alternative longer
isoform in addition to an isoform resulting from initiation
at a standard AUG codon downstream via a process
termed ‘leaky scanning’ (22). Where alternative isoforms
are produced as a result of leaky scanning, the longer
isoform frequently contains a signal for subcellular local-
ization that is absent in the shorter form (23–26). In some
cases of non-AUG-initiated genes, the principles of leaky
scanning ensure that the non-AUG initiation codon is the
sole initiation site of the main CDS even when down-
stream in-frame AUG codons exist. This happens when
the region between the non-AUG initiation codon and the
ﬁrst available downstream in-frame AUG codon is
populated by one or even many out-of-frame AUG
codons, especially if some of them occur in a good initi-
ation context as, for example, in the case of EIF4G2 (27).
Conversely, another peculiar feature of eukaryotic initi-
ation can be exploited to suppress initiation on intervening
out-of-frame AUG codon(s). Translation of open reading
frames (ORFs) shorter than approximately 35 codons
results in only partial dissociation of terminating ribo-
somes from the mRNA, with the 40S subunit able to
resume scanning downstream (11,28). Scanning following
translation of such an ORF, however, precludes efﬁcient
reinitiation until initiation factors have been reloaded
onto the 40S subunit. As a result AUG codons, even in
perfect (Kozak) context, are inefﬁciently recognized if they
are present  100–200nt downstream of an efﬁciently
translated short upstream ORF (29). Translation of an
ORF longer than approximately 35 codons usually pre-
cludes resumption of scanning downstream. An additional
layer of complexity comes from the fact that the efﬁciency
of ‘reloading’ the scanning 40S subunit following
translation of a short upstream ORF (uORF) is under
regulatory control through the phosphorylation status of
Ser-51 of eIF2a (29). Leaky scanning, combined with the
peculiar features of reinitiation following translation of
short uORFs, can result in diverse and complex scenarios
for predicting which codons, and under what conditions,
are recognized as initiation sites for translation on eukary-
otic mRNAs (22).
Earlier in vitro work with rabbit reticulocyte lysates
showed that the concentration of Mg
2+ negatively regu-
lates the ﬁdelity of translation initiation (18). A recent
study found that non-AUG-initiated uORFs regulate ex-
pression of ornithine decarboxylase homologs in many
eukaryotic organisms (30). In one of the mammalian
homologs, and perhaps in all other homologs that have
this particular regulatory feature, polyamines induce initi-
ation on an AUU codon. It is noteworthy that polyamines
are essentially organic polycations and, as such, their bio-
physical role overlaps with that of Mg
2+ ions which, at
least in vitro, show an identical effect on the ﬁdelity of
initiation. A recently developed technique for proﬁling
the ribosomal density on mRNAs revealed the presence
of translating ribosomes on >200 non-AUG-initiated
uORFs in yeast. Moreover, initiation on these uORFs
was shown to be upregulated under amino acid starvation
conditions (31). Another recent study showed that vari-
ations in the intracellular levels of eIF1 lead to signiﬁcant
differences in the stringency of start codon selection (32).
These results suggest that the ﬁdelity of initiation is
variable under physiological conditions and strongly
supports the idea that non-AUG initiation might
perform regulatory roles in eukaryotic cells. Therefore,
the utilization of non-AUG initiation in mammalian
mRNAs merits further exploration, as the regulated alter-
native usage of start codons provides an opportunity for
global alterations of a proteome in a coordinated manner.
An earlier ﬁnding that sequences in the 50-untranslated
regions (UTRs) are highly conserved and that the level
of conservation globally increases toward the UTR/CDS
boundaries (33) is suggestive that this conservation could
be due, in part, to the 30-ends of a portion of 50-UTRs
encoding N-terminal extensions to the annotated
AUG-initiated proteins. The protein coding potential of
50-UTRs and modes of its utilization have been discussed
in detail elsewhere (34).
Here we performed a systematic analysis of the 50-UTRs
of human GenBank RefSeq mRNAs to investigate the
extent of non-AUG initiation in humans. Our method-
ology is based on the analysis of codon substitution
rates in pairwise alignments of human and mice
orthologous sequences that allows us to detect 50-UTR
fragments evolving under the constraints of protein
coding evolution. If a segment of a 50-UTR evolves
under such constraints, it is likely that the corresponding
protein sequence is produced and is positively functional.
Candidates selected by this criterion were subjected to
further computational analysis using multiple alignments
of sequences from other vertebrate species followed by
rigorous manual evaluation.
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A pipeline for identiﬁcation of candidates for non-AUG
translation initiation
A schematic outline of the pipeline for potential 5
extension of CDS (P5EC) detection is illustrated in
Figure 2. A total of 46500 human mRNA sequences
were downloaded from the NCBI RefSeq database (35)
on 12 February 2009 (release 33) using the Refseq ftp
site: ftp://ftp.ncbi.nih.gov/refseq/release/. We chose
RefSeq annotations to minimize the effect from erroneous
and inconsistent misannotations as well as to avoid
redundancy in our dataset. All sequences that have
in-frame stop codons within 50 codons upstream of
annotated AUG initiator codons were discarded. For
the remaining mRNA sequences, the region surrounding
the annotated AUG codon was translated from the
nearest upstream in-frame stop codon to the 100th
codon downstream of the AUG. The inclusion of the
50-terminal 100 codons of the annotated CDS was a ne-
cessary element to ensure detection of correct mouse
orthologs in the following steps. This procedure resulted
in a set of 3437 peptide sequences. This set of peptide
sequences was then queried against the mouse Refseq
mRNA database using tblastn as implemented in NCBI
BLAST client netblast-2.2.19. The best hits for each of
the peptides were considered as candidate orthologs.
Those sequences that produced alignments with a span
of at least 50 codons upstream of the annotated CDS
were extracted for further processing; 2194 human–
mouse orthologous pairs were obtained. Sequences were
conceptually translated, re-aligned using muscle (36)
and back-translated using t_coffee utilite (37) to yield nu-
cleotide alignments. A custom perl script was designed
to trim P5EC alignments prior to Ka/Ks calculation in
the following way. Columns containing gaps in either
the human or mouse sequence were removed. Because
the alignment of sequences was carried out at the amino
acid level, all gaps at the nucleotide level occur in mul-
tiples of 3 and therefore their removal does not affect
reading frame. For alignments containing in-frame stop
codons in the mouse sequence, columns corresponding
to the stop codons and all columns upstream were
removed. This was done based on the assumption that,
in general, functionally important P5ECs and alternative
translation initiation starts (ATISs) should be conserved
between mouse and human sequences and that the
presence of a stop codon in a mouse sequence indicates
that the sequence is not translated in mouse. If, after
trimming, the resulting alignment was shorter than 25
codons, then the corresponding mouse P5EC could not
be longer than 25 codons. Also it would not be practical
to include such short alignments into further analysis.
Therefore, only alignments with a length of at least 25
codons upstream of the annotated AUG (1193 align-
ments) were subjected to Ka/Ks analysis as implemented
in the codonml program of the PAML package (38).
Then the alignments were scored based on Ka/Ks values,
length of the pairwise alignments and identity at the
protein level.
Identiﬁcation of candidates with known alternative
transcript variants
An additional step, as discussed in the ‘Results’ section,
was the identiﬁcation of those P5EC-containing mRNAs
whose genes are known to have alternative transcripts
containing 50-extensions to the annotated CDS. For this
purpose, annotations of mRNA sequences from the pool
above (1193) were searched for the following text strings:
‘transcript variant’ or ‘shorter’ preceding ‘N-terminal’
within the same annotation ﬁeld of GenBank format
RefSeq entries. Due to the lack of uniformity in annota-
tion descriptions, this procedure does not guarantee iden-
tiﬁcation of all mRNAs with alternatively spliced
transcripts where the CDS is 50-terminally extended.
However, this step allowed us to achieve two goals.
First, we eliminated a large portion (204 instances) of
genes where P5ECs exist because they correspond to
translated regions in alternative transcripts and hence
most likely do not utilize non-AUG initiation. Second,
we created a set of sequences that could be utilized as a
positive control, because these genes represent cases where
sequences upstream of annotated start codons are known
to be translated (see ‘Results’ section).
As described in the Results section, a relatively high Ka/
Ks ratio for the entire P5EC does not necessarily exclude
the possibility that at least the 30 part of the P5EC might
be evolving under purifying selection. Therefore, we used
a relatively relaxed threshold for choosing the candidates
for further detailed semi-manual analysis, i.e. Ka/Ks <1,
and the existence of a signiﬁcant human–mouse pairwise
alignment that spans at least 25 codons in length. Identity
at the nucleotide or protein level was not taken into
account at this point. This resulted in 742 candidates for
further analysis.
Analysis of the approximately 700 candidates using deep
phylogenetic analysis and manual evaluation
As it has been mentioned above, our ﬁlter for RefSeq
mRNAs containing P5ECs due to alternative splicing
was not exhaustive because of idiosyncrasies in RefSeq
annotation comments. Therefore, all 742 candidates
were subjected to further examination for the presence
of alternative splice forms using the Entrez Gene
database (39). All candidates containing alternative
splice or transcription initiation forms resulting in notice-
ably variable 50-ends were excluded from further analysis.
The sequences of those candidates that passed this step
were queried against human ESTs from dbEST (40)
using blastn. Retrieved ESTs were used to search for the
possible existence of non-annotated splice variants in the
vicinity of the 50-UTR-CDS junctions in the candidates
under examination. Sequences that showed multiple 50
variants, either resulting from alternative transcription
initiation or alternative splicing, not included in RefSeq,
but deemed likely to be real were, with a few exceptions,
removed from further consideration. The exceptions
were made for alternative transcripts that nevertheless
lacked any upstream in-frame AUG codons. Among the
set of genes that passed the ﬁlters above, we found
numerous cases where the 50-end extensions contained
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RefSeq sequence. Such examples were also excluded
from further analysis. For the candidates that passed
this step, the human extension up to the upstream
in-frame stop codon was conceptually translated and
queried against the dbEST, wgs and RefSeq_rna data-
bases to retrieve sequences from non-human species that
share signiﬁcant similarity with the query. If the coding
sequence was interrupted either by an in-frame stop codon
or a frameshift in sequences from multiple organisms (i.e.
>20% of the total available), especially if the conservation
at the amino acid level was weak, such candidates were
deemed questionable and were excluded from further
analysis. The ﬁnal criterion used to select for positives in
the screen was the presence of a well-conserved ‘near
cognate’ initiation codon for the putative extension. In
total, 36 genes passed all these tests.
Multiple sequence alignments were constructed for the
ﬁnal list of candidates, plus the previously identiﬁed cases
of upstream non-AUG-initiated extensions that passed the
same selection criteria, and analyzed using PAML
codonml (38,41) and MLOGD (42). Codonml was used
to recalculate Ka/Ks, now using the multiple species align-
ments instead of just human–mouse and restricting to the
region between the annotated AUG and the predicted
upstream non-AUG initiation codon. MLOGD calculates
coding potential by using the pattern of substitutions
observed within an input sequence alignment to compare
a coding model with a non-coding model via a likelihood
ratio test. Although Ka/Ks could not be calculated with
MLOGD (it is ﬁxed via the BLOSUM62 matrix used
within the coding model), MLOGD could be used to
produce graphs of coding potential versus sequence
position and could therefore be used to help identify the
most probable non-AUG initiation sites.
These alignments were also used to calculate the prob-
ability, P (no stop codons), that the ORF of the extension
would be preserved by chance if the sequence were
non-coding. For each alignment, nucleotide columns
were randomized 10000 times and the proportion of ran-
domizations in which the ORF was preserved (i.e. no stop
codons in the zero-frame in any sequence) was taken as an
estimate for P (no stop codons). The procedure controls
for the phylogenetic non-independence of aligned nucleo-
tides and any gene-speciﬁc nucleotide biases in the exten-
sion region (e.g. GC-rich regions tend to have fewer stop
codons and therefore tend, by chance, to have longer
ORFs). It also controls for gene-speciﬁc conservation
biases (e.g. in a 50-UTR that happens to be highly
conserved due to some non-coding functional element, a
chance ORF in one sequence is more likely to be preserved
throughout the alignment). One caveat with interpretation
of these P-values is that, for a small number of alignments,
stop-codon-containing sequences from a small number of
species had been previously discarded from the alignment
either as presumed sequencing errors or on the assumption
that the extension has been lost in some species. The P (no
stop codons) value was not used as part of the selection
criteria. In fact, most of the non-AUG-initiated extensions
identiﬁed here are not sufﬁciently long to have a statistic-
ally signiﬁcant P (no stop codons) value. However, it is
useful for a small number of cases where we identiﬁed a
very long extension that, nonetheless, was not subject to
strong purifying selection and hence had weak Ka/Ks and
MLOGD scores.
A similar randomization procedure was used to deter-
mine P-values for the MLOGD and Ka/Ks scores. Because
MLOGD and Ka/Ks are codon-based statistics, alignment
columns containing gaps were removed prior to random-
ization (otherwise, after randomization of nucleotide
columns, alignment gaps would no longer occur in
groups of three so reading frames would not be conserved
between species with and species without alignment gaps).
Due to CPU constraints, only 1000 randomizations were
used for each alignment, which restricts the resolution of
raw P-values to  0.001. In many cases, however, the
observed MLOGD and log(Ka/Ks) values (recalculated
for the same degapped alignments) were many standard
deviations away from the corresponding mean values for
the randomizations. To obtain higher resolution P-values
(shown in Table 1), a normal approximation was assumed
for the distribution of the randomization statistics for any
particular alignment (after log transform for Ka/Ks;
MLOGD is already on a log scale) and the probabilities
of obtaining the observed log(Ka/Ks) and MLOGD statis-
tics in randomized alignments were calculated with respect
to this distribution.
Analysis of ribosomal proﬁling data
Short reads generated during ribosomal proﬁling experi-
ments in HeLa cells described in Guo et al. (43) were
obtained from the Gene Expression Omnibus (accession
GSE22004). Short reads from all available experiments
(SRR057511, SRR057512, SRR057516, SRR057517,
SRR057521, SRR057522, SRR057526, SRR057529,
SRR057532) were aggregated and aligned to the 59
mRNA sequences using Bowtie short read aligner (44),
allowing zero mismatches in the ﬁrst 25nt ‘seed’ region.
According to Guo et al. (43), on average, mRNA nucleo-
tide positions corresponding to the 50-end of the short
reads in the alignments are located 15-nt upstream of
the P-site tRNA in the ribosome. Therefore, coordinates
of ribosome positions were calculated accordingly, i.e.
shifted by 15-nt downstream from the beginning of the
alignment between a short read and mRNA sequence.
During this analysis, we did not check whether particular
reads could be potentially aligned to other positions
within the human genome and therefore the absolute
numbers of footprints may be skewed. The density of ribo-
somes in CDSs and non-AUG extensions was calculated
as the absolute number of footprints corresponding to a
particular region divided by its length.
RESULTS
Analysis of P5ECs
Most protein-coding sequences evolve under purifying se-
lection and this feature can be used for detection of
protein coding regions in nucleotide sequences (45). If,
in a particular gene, translation initiates upstream of the
annotated start codon, then the sequence located between
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Rank RefSeq ID Gene name Start Extension
length,
codons
MLOGD P(MLOGD) Ka/Ks P(Ka/Ks) Blast score,
bits
P (no stop
codons)
Ribosomal footprints
(abs)/density
Extension Annotated
CDS
A) Newly identiﬁed non-AUG-initiated N-terminal extensions in this study
1 NM_001042589 TMEM8B CUG 295 71.69 2.4 10
 28 0.036 1.5 10
 46 566 <0.001 ND ND
2 NM_001037335 PRIC285 GUG 247 53.32 9.2 10
 14 0.185 2.5 10
 17 301 <0.001 (4)/0.01 (43)/0.01
3 NM_001010858 RNF187 CUG 109 45.37 4.4 10
 17 0.105 8.8 10
 17 168 0.094 (88)/0.27 (865)/2.26
4 NM_001136108 R3HCC1 CUG 187 51.31 1.2 10
 14 0.199 2.1 10
 18 264 <0.001 (158)/0.28 (0)/0.0
4 NM_003760 EIF4G3 AUC 187 26.61 5.4 10
 09 0.134 3.4 10
 12 217 <0.001 (43)/0.08 (616)/0.13
6 NM_006375 ENOX2 UUG 60 34.12 2.2 10
 07 0.139 2.3 10
 09 113 <0.001 (3)/0.02 (46)/0.03
7 NM_176677 FLJ36208 CUG 156 33.61 9.0 10
 10 0.211 1.1 10
 10 235 0.001 ND ND
8 NM_153756 FNDC5 AUA 75 18.47 9.0 10
 09 0.061 4.5 10
 10 132 0.04 ND ND
9 NM_006688 C1QL1 AUU 30 17.5 7.5 10
 06 0.023 5.8 10
 11 92.3 0.418 ND ND
10 NM_145008 YPEL4 ACG 35 27.12 3.1 10
 07 0.026 3.7 10
 12 70.5 0.318 ND ND
11 NM_182528 C1QL2 AUU 34 19.52 1.3 10
 06 0.022 5.3 10
 11 67.4 0.362 ND ND
12 NM_000314 PTEN CUG 173 11.26 1.5 10
 05 0.176 1.7 10
 05 190 <0.001 (33)/0.06 (292)/0.24
12 NM_139239 NFKBID CUG 142 25.37 1.7 10
 09 0.27 5.1 10
 08 182 <0.001 (16)/0.04 (1)/0.0
14 NM_001015072 UFSP1 CUG 76 18.84 9.2 10
 08 0.191 1.6 10
 07 122 0.056 ND ND
15 NM_020153 C11orf60 AUA 54 31.79 2.0 10
 07 0.197 5.2 10
 06 90.9 0.001 (3)/0.02 (110)/0.1
16 NM_001005404 YPEL2 ACG 33 25.32 1.2 10
 08 0.041 1.6 10
 12 63.9 0.232 ND ND
17 NM_020335 VANGL2 AUA 48 9.04 8.8 10
 04 0.069 1.7 10
 05 92 0.125 ND ND
18 NM_017457 CYTH2 CUG 45 16.03 3.7 10
 04 0.172 4.3 10
 04 78.2 0.292 (11)/0.08 (355)/0.29
18 NM_001010908 C1QL3 AUU 32 11.21 9.0 10
 05 0 1.6 10
 33 61.6 0.309 ND ND
20 NM_001008223 C1QL4 AUU 31 23.04 3.1 10
 06 0.071 4.6 10
 08 58.5 0.202 ND ND
21 NM_001002914 KCTD11 AUU 39 14.33 3.3 10
 06 0.035 1.9 10
 10 55.5 0.241 (1)/0.01 (19)/0.03
22 NM_025160 WDR26 ACG 100 14.32 1.6 10
 05 0.255 1.0 10
 04 61.2 0.004 (42)/0.14 (785)/0.4
23 NM_005078 TLE3 CUG 52 3.68 2.3 10
 03 0.399 9.8 10
 03 87.4 0.248 (10)/0.06 (346)/0.15
24 NM_002250 KCNN4 GUG 25 2.74 3.4 10
 02 0.367 6.2 10
 02 74.9 0.255 (44)/0.58 (346)/0.27
25 NM_004494 HDGF GUG 50 9.53 2.5 10
 04 0.274 1.2 10
 03 61.2 0.405 (119)/0.79 (3373)/4.66
26 NM_013313 YPEL1 ACG 35 9.86 1.2 10
 04 0.194 2.3 10
 05 39.7 0.009 ND ND
27 NM_022106 C20orf177 AUA 58  1.56 1.2 10
 01 0.388 4.4 10
 02 76.6 <0.001 (43)/0.25 (14)/0.01
28 NM_006079 CITED2 CUG 21 1.81 4.6 10
 02 0.246 2.5 10
 02 59.2 0.28 (76)/1.19 (165)/0.2
29 NM_182603 ANKRD42 CUG 300  94.17 3.7 10
 04 0.42 1.5 10
 14 157 <0.001 (21)/0.05 (27)/0.02
30 NM_014310 RASD2 CUG 107  9.31 2.5 10
 03 0.424 6.2 10
 05 111 0.006 ND ND
31 NM_002506 NGF UUG 44 0.11 9.4 10
 03 0.556 2.2 10
 01 72 0.002 (47)/0.35 (97)/0.19
32 NM_152283 ZFP62 GUG 60 8.05 3.2 10
 03 0.345 2.7 10
 03 41.2 <0.001 (32)/0.18 (47)/0.02
33 NM_001102654 NTF3 UUG 23  3.4 9.3 10
 02 0.426 6.6 10
 02 70.6 0.029 ND ND
34 NM_003252 TIAL1 GUG 90  12.92 6.5 10
 02 0.676 1.6 10
 01 103 0.09 (34)/0.13 (1258)/1.11
35 NM_024794 EPHX3 ACG 37 8.88 4.2 10
 04 0.391 1.9 10
 03 27.3 0.044 ND ND
36 NM_018646 TRPV6 ACG 40 1.56 7.3 10
 04 0.438 2.1 10
 03 52.4 0.016 ND ND
36 NM_033315 RASL10B UUG 33  4.78 1.3 10
 01 0.418 3.7 10
 02 55.1 0.111 ND ND
38 NM_001080510 C17orf95 CUG 63  0.36 8.2 10
 03 0.432 5.1 10
 03 49.3 0.01 (8)/0.04 (205)/0.35
39 NM_023110 FGFR1 ACG 43  9.22 5.1 10
 01 0.684 4.2 10
 01 62.8 0.022 (21)/0.16 (141)/0.06
40 NM_153369 KIAA1919 CUG 54  2.32 1.1 10
 02 0.559 4.2 10
 02 52.4 0.024 ND ND
41 NM_001144886 CITED1 CUG 17  2.86 6.6 10
 02 1.039 7.5 10
 01 33.7 0.082 ND ND
42 NM_006645 STARD10 GUG 34  10.8 4.7 10
 01 0.739 4.0 10
 01 47.4 0.015 (2)/0.02 (12)/0.01
B) Previously reported non-AUG-initiated N-terminal extensions
1 NM_002097 GTF3A CUG 235 126.73 2.8 10
 34 0.104 2.0 10
 33 404 <0.001 (144)/0.2 (78)/0.2
2 NM_001418 EIF4G2 GUG 206 16.21 9.1 10
 06 0 4.7 10
 46 421 <0.001 (2832)/4.58 (3638)/1.83
3 NM_001017371 SP3 AUA 217 55.29 7.9 10
 16 0.129 3.5 10
 15 346 <0.001 (96)/0.15 (570)/0.38
3 NM_175886 PRPS1L1 ACG 67 46.73 5.2 10
 14 0.005 1.5 10
 36 132 0.002 (494)/2.45 (244)/0.32
5 NM_003213 TEAD4 UUG 73 40.13 1.8 10
 09 0.054 2.2 10
 12 135 0.014 (257)/1.17 (247)/0.23
6 NM_003214 TEAD3 AUA 65 34.03 7.2 10
 11 0.045 1.9 10
 12 110 0.045 (52)/0.27 (63)/0.06
6 NM_031895 CACNG8 CUG 34 49.14 6.0 10
 17 0.02 2.0 10
 27 69.3 0.007 ND ND
8 NM_016178 OAZ3 CUG 48 47.48 2.8 10
 08 0.249 8.4 10
 05 88.6 <0.001 ND ND
9 NM_021961 TEAD1 UUG 22 6.75 5.5 10
 03 0.112 4.5 10
 03 73.6 0.335 (3)/0.04 (451)/0.36
9 NM_001098504 DDX17 ACG 57 21.96 3.5 10
 06 0.192 8.2 10
 06 68.9 0.044 (81)/0.34 (4333)/2.21
11 NM_001025366 VEGFA CUG 180  4.09 9.8 10
 04 0.539 6.6 10
 03 190 <0.001 (162)/0.3 (89)/0.13
11 NM_022002 NR1I2 CUG 55 19.39 1.5 10
 05 0.289 3.8 10
 04 68.2 <0.001 ND ND
11 NM_001172131 HCK CUG 21 13.67 3.9 10
 05 0.157 2.8 10
 04 62.1 0.396 ND ND
11 NM_000378 WT1 CUG 73 8.27 2.9 10
 05 0.339 2.8 10
 06 73.2 0.005 ND ND
15 NM_001172415 BAG1 CUG 71  4.11 2.8 10
 03 0.49 3.4 10
 03 82 0.096 (222)/1.04 (1136)/1.38
16 NM_001099456 NPW CUG 52 0.71 4.6 10
 03 0.315 4.1 10
 04 48.5 0.109 ND ND
17 NM_002467 MYC CUG 15  8.4 8.2 10
 01 1.046 6.8 10
 01 0 0.118 (279)/6.07 (4864)/3.68
Column 1, combined ranking; column 2, GenBank accession number; column 3, gene name; column 4, predicted non-AUG initiation codon in human (see
Supplementary Dataset 1 for full details); column 5, length in codons of predicted N-terminal extension in human; column 6, MLOGD score (negative values
are shown in red and indicate candidates subject to weak or no purifying selection); column 7, P-value for MLOGD score based on randomizations; column 8,
Ka/Ks ratio (with gap-containing columns removed from the alignment); column 9, P-value for Ka/Ks based on randomizations; column 10, BLAST bits score
measured on the alignment of the human and mouse extensions; column 11, probability of the ORF of the extension being preserved by chance if non-coding.
Note that the MLOGD score scales with alignment length and divergence and the BLAST bits score scales with length. The ﬁnal ranking is based on the
average of rankings by the individual scores (MLOGD, Ka/Ks and BLAST bits). Columns 12 and 13 give information on the number of mRNA fragments
protected by ribosomes for extension (column 10) and annotated CDSs (column 11). The absolute number of footprints and density of footprints are separated
by a backslash. Density is calculated as the absolute number divided by the length of the mRNA fragment (extension or CDS). ‘ND’, not detected. A) Ranking
of the 42 newly identiﬁed non-AUG extensions. GenBank accession numbers highlighted in green represent extensions that are conserved beyond mammals
and for which all available sequences from vertebrates appear to utilize non-AUG initiation codon(s); accession numbers highlighted in light blue represent
extensions that are conserved beyond mammals and for which some or all non-mammalian sequences appear to utilize AUG instead of non-AUG initiation;
accession numbers highlighted in magenta represent extensions that are initiated by AUG codons in at least some mammals; accession numbers highlighted in
yellow represent extensions that are conserved only in mammals (in some cases only eutherian mammals) and which are never initiated by AUG codons.
B) Ranking of previously reported non-AUG extensions.
4224 Nucleic Acids Research, 2011,Vol.39, No. 10the annotated start codon and the actual (upstream) start
codon should evolve under constraints of purifying selec-
tion. For brevity, we will refer to such regions as P5ECs.
We used the existence of P5ECs as an initial indicator of
utilization of alternative initiator codons. In principle, the
presence of a P5EC does not guarantee that an alternative
in-frame start codon is used for initiation. Figure 1 illus-
trates ﬁve possibilities (examples for which are known)
where the sequence upstream of, and in-frame with, an
annotated start codon would evolve under purifying selec-
tion: (i) Initiation at an upstream in-frame non-AUG
codon (ATIS), the subject of this study. (ii) Programmed
Ribosomal Frameshifting (PRF), where initiation occurs
at the start codon of a uORF and then ribosomes enter the
main protein-coding ORF (pORF) by shifting reading
frames at a speciﬁc location. The most prominent
human examples are the three antizyme paralogs (46).
(iii) Stop Codon Readthrough (SCR). Similar to the
above but where the uORF and the pORF occur in the
same translational phase and are separated by a single
Stop Codon. No chromosomal genes are known to
utilize this phenomenon in humans but, in ﬂies, three
examples have been experimentally identiﬁed (47) and
>100 additional candidates have been identiﬁed by com-
parative sequence analysis (48). (iv) RNA editing. A start
codon is generated post-transcriptionally by the insertion
of a U between an A and a G, as has been suggested for
the linker histon H1F0 and HMGN1 protein genes (49).
(v) Alternative Splicing. An exon containing a start codon
in one transcript variant could be skipped in another tran-
script variant. In this case the latter transcript would use
an initiator codon located downstream of the start codon
of the former transcript. However the region between the
30-end of the Alternatively Spliced Exon (ASE) and the
start codon used in the second transcript would still
evolve under the constraints of protein coding sequence,
because this region is translated in the ﬁrst transcript
variant. This ﬁfth class of P5EC-containing mRNAs is
the largest class. Therefore, during our analysis we paid
particular attention to discriminate P5ECs occurring as a
result of alternative splicing from those resulting from
non-annotated translation events. The pipeline for the
initial computational analysis of human Refseq mRNAs
is outlined in Figure 2 and is described in detail in the
‘Materials and Methods’ section.
Comparison of P5ECs due to alternative splicing with the
other P5ECs
After obtaining Ka/Ks values for P5EC regions, we
generated a set of sequences where the presence of a
P5EC is due to the existence of alternative splice
variants (see ‘Materials and Methods’ section). We
compared the distribution of Ka/Ks values for these
P5ECs with the Ka/Ks values for the remaining P5ECs.
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Figure 1. Five known molecular mechanisms responsible for the initiation of translation upstream of the ﬁrst 50 in-frame AUG codon. mRNAs are
shown as horizontal lines. Dark grey boxes represent annotated CDS regions. Light grey boxes represent extensions of CDSs upstream of annotated
AUG codons up to the closest in-frame stop codon. Black boxes denoted as P5EC represent upstream regions where codons in-frame with annotated
CDSs evolve under purifying selection. Diagonal stripes are used to denote alternatively spliced exons.
Nucleic Acids Research, 2011,Vol.39, No. 10 4225The distribution is shown in Figure 3 (see Supplementary
Data for the actual values for each sequence). The distri-
bution of Ka/Ks values for mRNAs with known alterna-
tive transcript variants (containing CDS 50 extensions) is
signiﬁcantly sharper than the distribution of Ka/Ks values
for the rest of the P5ECs, with the great majority of them
falling under 0.2. Therefore, Figure 3 clearly illustrates
that Ka/Ks can be used as a predictor of bona ﬁde CDS
50 extensions. Figure 4 shows scatter plot distributions of
Ka/Ks ratios for sequences from both data sets in relation
to the length of P5EC (upper panels) and the level of
identity between mouse and human orthologs at the
protein level. While P5ECs from both datasets have
highly variable length, it is clear that those resulting
from alternative transcript variants have, on average,
higher identity at the protein level as well as lower Ka/Ks
values. While low Ka/Ks ratio and high protein identity are
good indicators of translated P5ECs, high Ka/Ks ratio and
low protein identity does not necessarily means that a
P5EC is not translated. This is because, at this stage of
the analysis, the statistics were calculated for the entire
region between the annotated AUG codon and the
nearest in-frame stop codon in the 50-UTR. However, if
alternative initiation occurs closer to the 30-end of a P5EC,
then the region of the P5EC upstream of the ATIS would
not evolve under the constraints of protein coding evolu-
tion and the cumulative values of Ka/Ks and of protein
identity for the entire region would be intermediate
between values typical of coding and non-coding se-
quences. Therefore, we used a relatively relaxed Ka/Ks
ratio threshold for selecting the candidates for further
detailed analysis (see ‘Materials and Methods’ section).
Identiﬁcation and analysis of candidates
After a series of automated, semi-automated and manual
steps that are described in detail in ‘Materials and
Methods’, 36 candidates satisﬁed the criteria of our
search. One of them, Wilms tumor 1 homolog, has a
reported non-AUG initiation in mouse which is homolo-
gous to the extension in human and, therefore, the gene
was grouped with the known examples of non-AUG ini-
tiation discussed elsewhere in this study. In almost all
cases, the putative 50 extensions in the candidates are
bracketed upstream by in-frame stop codons in at least
one and often many species, thus precluding the existence
of an upstream AUG codon for initiation of translation
for the extension. In some of the 35 examples, it appears
that the occurrence of non-AUG initiation is conserved
throughout vertebrates. This is also the case for the
known non-AUG extensions in TEAD1, TEAD3,
TEAD4 (50) and EIF4G2 (51). Vertebrate genes have
numerous paralogs that originated as a result of
large-scale DNA duplications in an early chordate (52).
For example, TEAD1 has three human paralogs in two
of which a non-AUG-initiated N-terminal extension is
present and conserved throughout vertebrates. When util-
ization of non-AUG initiation is ancient for a particular
gene, as evident by conservation up to the root of the
vertebrate tree, it can be expected that its paralogs may
also employ this mechanism. We investigated whether
non-AUG extensions are present in paralogs of the 35
provisional positives in our search, especially deeply
conserved ones. This led to the identiﬁcation of seven add-
itional candidates that had escaped initial detection due to
limitations in our rigorous selection criteria at various
stages of the pipeline.
In the next step, the nature and depth of conservation of
the extension in the 42 candidates were probed in
non-human/mouse species. In 10 cases (C1QL1, C1QL2,
C1QL3, C1QL4, YPEL1, YPEL2, YPEL4, WDR26,
FLJ36208 and VANGL2), 7 of them belonging to two
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Figure 2. Pipeline of RefSeq mRNA analysis for the identiﬁcation of
conserved 50 CDS extensions (P5ECs). White boxes indicate annotated
CDSs. Black boxes correspond to 50 in-frame codon extensions up to
the closest in-frame stop codon. Xs correspond to the deleted regions of
human–mouse alignments prior to Ka/Ks analysis.
4226 Nucleic Acids Research, 2011,Vol.39, No. 10paralogous clusters, both the extension and its non-AUG
initiation appear to be conserved in all vertebrates for
which sequence is available (examples highlighted in
green in Table 1). In nine other cases, the extension also
appears to be conserved in most or all vertebrates but the
non-AUG initiation is conserved only in mammals (high-
lighted in blue in Table 1). In a further eight cases, the
extension appears to be conserved only in mammals and in
some of them (usually a minority) it is initiated by AUG
either at the position of the putative human non-AUG
initiation codon or in its vicinity (highlighted in magenta
in Table 1). In two of them the non-AUG initiation
evolved recently as all non-primate species have AUG ini-
tiation in place of the human non-AUG initiation codon.
In one of these, FNDC5, the putative non-AUG initiation
is speciﬁc to humans while in chimp and gorilla an AUG
codon appears to be utilized instead. In the ﬁnal 15, the
extension is conserved only in mammals and is always
initiated by a non-AUG codon (highlighted in yellow in
Table 1).
In half (i.e. 21) of the newly identiﬁed non-
AUG-initiated extensions, one to six out-of-frame AUG
codons exist between the putative non-AUG start site and
the next available in-frame AUG codon downstream. In
Figure 3. Histogram of Ka/Ks values for mRNA sequences with known 50 extensions. White bars represent mRNAs for which alternative transcripts
with extended CDSs are known and therefore corresponding extensions are known to be translated in alternative transcripts. Sequences of these
extensions are expected to evolve as protein coding sequences and were used as an internal control in this study. Black bars represent the remaining
mRNAs for which it is not known whether alternative mRNA isoforms exist. Curves indicate the number of genes (y-axis) with Ka/Ks below a
particular value (x-axis).
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Figure 4. Scatter plots of Ka/Ks ratios for the alignments of the sequences corresponding to P5ECs from different mRNAs (y-axis) in relation to the
level of protein identity (bottom panels), and the lengths of P5ECs (top panels). The right-hand panels correspond to mRNAs for which transcript
variants with 50-extended CDSs are known. The left panels correspond to the remaining mRNAs.
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and perhaps in some others, the downstream in-frame
AUG would not be available for initiation, and transla-
tion of the main CDS would occur solely via the upstream
non-AUG initiation site. Conversely, in the 21 extensions
lacking any out-of-frame AUG codons, a signiﬁcant pro-
portion of ribosomes would be predicted to reach the
in-frame AUG codon via leaky scanning, resulting in the
translation of multiple C-terminally coincident isoforms.
In addition to the 23 human non-AUG utilizing genes
compiled previously (21), we found six others either in the
published literature or with annotated non-AUG initi-
ation in RefSeq. To help with the evaluation of the can-
didates reported here for the ﬁrst time, these 29 known
human cases of non-AUG initiation were subjected to the
same qualitative analysis as described above for the new
candidates. Seventeen known extensions exhibit a conser-
vation pattern similar to the 42 new candidates, while the
remaining 12 do not pass the rigorous qualitative tests for
conservation used to identify the 42 new candidates. This
analysis also showed that in TEAD1, a UUG codon
further upstream, in addition to the previously identiﬁed
AUU codon (53), is perfectly conserved and is likely to
also serve as an initiation codon. In DDX17, the previ-
ously proposed CUG initiator (54) is not well conserved;
however, tandem ACG-GUG codons downstream are
perfectly conserved and are the more likely initiation
site(s).
The total size of all 42 newly identiﬁed extensions is
3374 codons; the average size is 80.3 codons and the
median is 51 codons. In the 17 known cases that passed
the qualitative test, the average extension is 87.7 codons
and the median is 65 codons. Among the newly identiﬁed
non-AUG-initiated extensions, the shortest is 17 codons
and the longest is 300 codons. Among the 17 known and
conserved non-AUG-initiated extensions, the shortest is
15 codons and the longest is 235 codons, see Figure 5
for distribution of extension lengths. The annotated se-
quences of mRNAs described in Table 1 are available in
the Supplementary Dataset 1.
Of the 9 possible codons that differ from AUG in a
single position, 5 are used to initiate the extensions of
the 17 known cases that passed our qualitative analysis
for conservation of the extension. By far the most
commonly used is CUG, 10 times (59%), followed by
ACG, AUA and UUG with two occurrences of each,
and GUG with one occurrence. The distribution of the
putative initiation codons of the 42 new candidates in
humans is not radically different (notwithstanding the po-
tential for observer bias in locating the precise initiation
codon in a small number of cases). Seven of the nine
possible codons appear to be utilized, with only the very
inefﬁciently recognized AGG and AAG not used. The dis-
tribution of the 7 used is: 15 CUGs (36%), 7 ACGs, 6
GUGs, 5 AUUs, 4 each of UUG and AUA and, ﬁnally,
1 AUC. This order correlates with the efﬁciency of initi-
ation for each non-AUG codon, with CUG the most efﬁ-
cient of them all (16). In addition to the identity of the
initiation codon, the initiation context of the 17 previously
known examples that passed the screening process and the
42 newly identiﬁed candidates were examined (Figure 6).
Once again the pattern is similar in both cases though the
previously identiﬁed cases are closer to the optimal
context for mammalian genes.
The 42 candidates and the 17 known examples were
subjected to a more precise quantitative analysis,
including calculation of Ka/Ks (38,41) and MLOGD (42)
scores for multiple sequence alignments of up to 32 verte-
brate species, and blast bits scores for human–mouse
alignments, as described in ‘Materials and Methods’.
Candidates were ranked separately by the Ka/Ks ratio,
MLOGD score and the BLAST bits score and then the
rankings were averaged. The results of these analyses are
shown in Table 1. As a general rule, extensions that rank
Figure 5. Boxplots of non-AUG CDS extension length distributions
for previously known cases and those identiﬁed in this study.
Figure 6. Weblogo representation of the region surrounding the known
and putative conserved non-AUG initiation sites in humans.
Numbering is relative to the ﬁrst nucleotide of the start codon.
(A) Representation for the 42 sequences with newly identiﬁed exten-
sions. (B) Representation for the 17 sequences with previously identiﬁed
and conserved extensions. (C) Representation of all AUG start sites of
humans [the frequencies for nucleotide occurrence at each position for
the human mRNAs were obtained from the Transterm database (73)].
4228 Nucleic Acids Research, 2011,Vol.39, No. 10near the top and that show conservation beyond mammals
are far more likely to be physiologically signiﬁcant.
Conversely, extensions that rank near the bottom are
conserved only in mammals, are never initiated by AUG
codons in any species and are less likely to be physiolo-
gically signiﬁcant even if they are in fact translated.
Independent experimental evidence for the non-AUG
extensions from Western blot data
For 6 of the 42 candidates identiﬁed in our analysis, pub-
lished western blot data provide independent experimental
support for translation of the non-AUG-initiated exten-
sion in vivo (see Supplementary Dataset 2). These include:
Ankyrin repeat domain 42 (ANKRD42), also known as
several ankyrin repeat protein (SARP), is known to
interact with protein phosphatase 1. Browne et al. (55)
described the original cloning of the human gene and
reported the presence of two protein isoforms in vivo,
one with an apparent molecular weight of 92–95kDa
and another with a molecular weight of 65kDa. Without
supporting evidence, they assumed that the two products
result from translation on two alternatively spliced
mRNA variants represented by two cloned complemen-
tary DNAs (cDNAs): DQ508934 (for the longer
isoform) and DQ508815 (for the shorter isoform). This,
however, is contradicted by a northern blot presented in
the same report [Figure 3F in (55)] which shows a single
mRNA species of approximate size 3.6kb. The authors
also noted that their longest clone, DQ508934, does not
have an in-frame AUG that could initiate a 92- to 95-kDa
protein. They then assumed that the AUG must be present
in the genomic region just upstream of the 50-end of the
longer cDNA clone. Such an AUG is indeed present in the
genomic DNA of humans, 16nt upstream of the 50-end of
DQ508934, but there is no evidence that this region is
transcribed. In fact, although approximately 50 human
ESTs exist for the 50-end of ANKRD42, not a single one
extends beyond the 50-end of DQ508934. In the orthologs
in mouse, dog, orangutan, cattle and other mammals, de-
limiting upstream in-frame stop codons exist that unam-
biguously occur 30 of any in-frame AUG codons that
might come from the upstream genomic region. The
simplest explanation for the protein species observed
in vivo is that they correspond to alternative translation
initiation from a conserved CUG codon in a good initi-
ation context (producing the extension ranked 29th in
Table 1), and the next in-frame AUG codon located
 900nt downstream. These products have expected mo-
lecular weights of 89.6 and 57.3kDa, respectively, close to
the observed 92–95 and 65kDa. It is signiﬁcant that, in the
900nt space between the conserved CUG and ﬁrst
in-frame AUG, there is a single out-of-frame AUG in
humans that is immediately followed by a stop codon
and is therefore unlikely to signiﬁcantly affect scanning
ribosomes that failed to initiate on the CUG. In mice
and rats, however, six out-of-frame AUG codons are
present between the CUG and the ﬁrst in-frame AUG.
Thus, in these species, one would predict synthesis
of only a single protein isoform, i.e. the longer
CUG-initiated form (unless alternative transcripts are
produced).
Surprisingly, considering the direct evidence for its
in vivo expression, the data shown in Table 1 suggest
that in this case the 50 extension does not actually evolve
under strong purifying selection (Ka/Ks   0.4). Yet the
existence of such a long extension (lacking any in-frame
stop codons) in most mammalian orthologs strongly
argues that the extension is indeed translated.
Hepatoma-derived growth factor (HDGF), also known
as high-mobility group protein 1-like, is a developmentally
regulated pulmonary endothelial cell-expressed angiogenic
factor. HDGF northern blots identiﬁed a single 2.3-kb
mRNA in many rat tissues (56). Western blot analysis
on human microvascular endothelial cells revealed the
presence of at least two protein species—one major with
apparent size of 43kDa and one minor with apparent size
of 48kDa (57). Examination of available ESTs aligning
with human HDGF reveals evidence for alternative
mRNA variants resulting from different transcription ini-
tiation sites and a different exon 1, but none of the ESTs
contains an additional in-frame AUG upstream of the
previously identiﬁed initiation codon. Our analysis
predicts that the human HDGF mRNA encodes a
50-amino acid extension initiated by a GUG codon in
good context, with both the GUG codon and the
context conserved in mammals (ranked 25th in Table 1).
In several species, e.g. pig and dog, an upstream delimiting
stop codon exists. Initiation on the GUG and on the
downstream AUG codon is expected to produce protein
products with estimated molecular weights of 31.6 and
26.8kDa, respectively. Neither of these coincides with
the observed products on SDS western blots (48 and
43kDa), but the difference between the two observed
products ( 5kDa) is nearly identical to the difference
between the two predicted products. No out-of-frame
AUG codons exist between the GUG and AUG codons.
Thus, it appears that standard leaky scanning is sufﬁcient
to account for the observed protein products.
Mammalian eukaryotic translation initiation factor 4 g
3 (EIF4G3, more commonly known as eIF4GII) is a part
of the cap-binding protein complex of eukaryotic transla-
tion initiation factor 4F. EIF4GII has two known
paralogs, eIF4G1 (also known as eIF4GI) and eIF4G2.
The latter is known to be initiated at a non-AUG codon
(27,51). The study reporting the cloning and initial char-
acterization of eIF4GII identiﬁed a single mRNA species
by northern blot in humans with a size of 6.0kb (58). The
measured size of the endogenous protein was  220kDa.
Another band is present on western blots of the native
eIF4GII which is  20kDa above the main band. This
band is unremarked in the main text, but it is clearly
visible in Figure 3B lane 2 of Gradi et al. (58). The size
difference between the two native bands is  20kDa. This
is close to the difference between the predicted sizes of the
AUC- and AUG-initiated products (extension ranked
fourth in Table 1). The proposed AUC initiation codon
and its context are conserved in all mammals for which
sequence information is available. Curiously, the 4nt sur-
rounding the putative AUC codon, AAAAUCC ( 3 and
+4 positions underlined), which include the initiation
Nucleic Acids Research, 2011,Vol.39, No. 10 4229context, are identical to the equivalent positions of
AUU-initiated uORFs in mammalian antizyme inhibitor
and the 50-CUG-initiated N-terminal extension of mam-
malian antizyme 3 (30).
The non-AUG initiation in EIF4G2 and EIF4G3 is
very intriguing because it implies possible autoregulation
and hence a role for these two proteins in modulating the
stringency of start codon selection. If such autoregulation
exists, it would be analogous to the recently discovered
autoregulation of eIF1 (see ‘Discussion’ section). So far,
however, neither protein has a known role in the strin-
gency of start codon selection.
RASD family, member 2 (RASD2, alternatively known
as Rhes) is a Ras homolog and is also related to other Ras
GTP-binding proteins. It is predominantly expressed in
the striatum of mammalian brains. Mouse experiments
with RASD2 reveal behavioral abnormalities when the
gene is inactivated (59). Our analysis identiﬁed a
CUG-initiated extension encoded by the RASD2 mRNA
that is conserved in mammals and ranked 30th in Table 1.
The knockout analysis is accompanied by western blots on
striatum extracts from wild-type and Rasd2
 /  animals
(59). In mice the CUG-initiated peptide has an expected
size of 41.2kDa while downstream in-frame AUG initi-
ation would result in a protein with a predicted molecular
weight of 30.2kDa. The western blots show three protein
products present in the wild-type animals but not in the
knockout. One, with an apparent molecular weight of
31kDa, is nearly identical to a band that appears in
HeLa cells transfected with a Rasd2 construct lacking
the extension, thus suggesting that this is the product of
initiation from the AUG codon. The two other Rasd2-
speciﬁc products on the western blot have apparent sizes
of 39 and 48kDa. It seems likely that one (or both) of
these corresponds to the CUG-initiated protein product.
Available human and mouse ESTs do not provide support
for the existence of alternative transcripts that could be
used to explain the presence of the larger product.
Neurotrophin 3 (NTF3) is a target-derived neurotroph-
ic factor. NTF3 and its paralogs, nerve growth factor,
brain-derived neurotrophic factor, neurotrophin 4/5 and
neurotrophin 6, bind to both low- and high-afﬁnity recep-
tors on target cells to elicit a cascade of intracellular re-
sponses to produce their biological effects. Disruption of
NTF3 leads to severe sensory and sympathetic deﬁcits that
are incompatible with postnatal life in mice (60). Our
analysis indicates the presence of a UUG-initiated exten-
sion in human NTF3 (ranked 33rd in Table 1). An
antibody for NTF3 is commercially available from
Abcam. The product description page shows a western
blot with NTF3 antibody detecting two bands—one
with an apparent size of 30kDa and one with a size of
32kDa, closely matching the predicted sizes of NTF3
initiated at the UUG (33.3kDa) and at the downstream
in-frame AUG (30.8kDa).
WD repeat domain 26 (WDR26) is a WD40
repeat-containing protein that might be involved in
signal transduction and might affect transcriptional regu-
lation (61). The protein is highly conserved from humans
to yeast. Our analysis identiﬁed a well-conserved ACG/
CUG-initiated extension in vertebrates that is present
from human to ﬁsh, and ranked 22nd in Table 1. In
humans the AUG- and ACG-initiated proteins have
expected molecular weights of 72.1 and 81.3kDa, respect-
ively. An antibody for WDR26 is commercially available
from Abcam. The product description page shows a
western blot that displays two different bands correspond-
ing to proteins with apparent sizes of 80kDa, for the main
product, and 90kDa for the minor product. The  10kDa
difference between the two corresponds closely to the dif-
ference expected for initiation on the conserved ACG and
on the ﬁrst in-frame AUG codon.
Curiously, the published annotations of this gene (and
the previous version of the Refseq mRNA NM_025160.5)
not only omit the non-AUG initiated extension but also
the well-conserved ﬁrst in-frame AUG, and instead
assume that initiation occurs on the second in-frame
AUG codon (61,62). (Note, however, that the latest
version of the Refseq entry NM_025160.6 [updated
during preparation of this article on 21 July 2010] has
the CDS starting from the ﬁrst in-frame AUG.)
Orthologs of WDR26 in non-vertebrate metazoans were
identiﬁed and investigated for the presence of the
non-AUG-initiated extension. The gene in Drosophila
has an AUU-initiated extension that is conserved in
other ﬂies though not in mosquitoes. It appears that
the extension arose independently in vertebrates and in
ﬂies.
Evidence of non-AUG initiation from ribosomal
proﬁling data
The second set of experimental data supporting our pre-
dictions was obtained from recently published ribosomal
proﬁling experiments carried out in human cells (43). In
this work, mRNA fragments protected by ribosomes were
converted into a library of oligonucleotides and subjected
to massively parallel sequencing. The alignment of corres-
ponding sequences onto sequences of mRNAs allows de-
tection of ribosomal locations and the density of the
ribosomes on mRNA. We have aligned raw sequences
obtained by Guo et al. (43) using the bowtie program
(44) and quantiﬁed locations of the ribosomes on the
mRNA sequences where non-AUG initiation was pre-
dicted (see ‘Materials and Methods’ section). We have
been able to extract reads for 32 of 59 genes. Examples
of ribosomal proﬁles for NM_004494 and NM_001010858
are shown in Figure 7. For the other sequences, the
number of footprints corresponding to CDS and
non-AUG extensions, as well as ribosomal density in
these regions, are given in Table 1. The presence of ribo-
somal proﬁles in the extensions upstream of annotated
CDSs indicates that initiation takes place upstream of
annotated AUG initiation codons and supports our pre-
dictions regarding non-AUG initiation.
Other noteworthy candidates for non-AUG initiation
Ecto-NOX disulﬁde-thiol exchanger 2 (ENOX2, also
known as tNOX) is a hydroquinone and NADH oxidase
with protein disulﬁde-thiol interchange activity (63). It is
associated with the outer leaﬂet of the plasma membrane
at the surface of cancer cells and in sera of cancer patients
4230 Nucleic Acids Research, 2011,Vol.39, No. 10but is absent from the surface of non-cancer cells and from
sera of healthy individuals (64). Full-length tNOX mRNA
is present in both normal and cancer cells, but its transla-
tion is apparently inhibited in normal cells. Our analysis
identiﬁed an N-terminal extension of 60 amino acids,
likely initiated at an upstream UUG codon. The
non-AUG initiation is conserved only in mammals, but
the extension itself appears conserved in most
non-mammalian vertebrates where it is initiated by an
AUG codon. The gene ranks sixth in the analysis shown
in Table 1 and is strongly supported by evolutionary
evidence derived from codon substitutions in multiple
alignments.
The mRNA of tNOX has a feature that perhaps
explains the low level of expression of this protein in
normal cells. The region between the UUG and the down-
stream in-frame AUG contains an out-of-frame AUG
codon in very strong initiation context which starts a
22-codon ORF. The length of this ORF is close to that
considered to prevent reinitiation following its translation.
Therefore, the role of this short ORF is likely to inhibit
AUG initiation of the main CDS thus ensuring that trans-
lation of the main CDS is almost solely dependent on
initiation at the upstream inefﬁcient UUG.
Western blots for tNOX are available but are not in-
formative about the utilization of the extension in vivo.
The detected product is 34kDa which is only a fraction
of the predicted size, 66.6kDa, of even the AUG-initiated
polypeptide, thus indicating extensive post-translational
processing.
Not much is known about the function of the gene R3H
domain and coiled coil containing 1 (R3HCC1). The
protein is well conserved in mammals. Two features of
R3HCC1 make it particularly striking with regard to its
proposed non-AUG initiation. The ﬁrst is the existence of
six out-of-frame AUG codons between the putative CUG
initiation codon in humans, present in perfect Kozak
context, and the next available in-frame AUG codon, as
mentioned above. This conﬁguration is also present in the
other six available mammalian sequences which, on
average, have 5.2 out-of-frame AUG codons in this
region. The second is the fact that the position of this
ﬁrst available in-frame AUG codon is variable and, in
cattle (Bos taurus), it is just eight codons away from the
stop codon. In cattle, as indeed in all other mammals, an
upstream in-frame delimiting stop codon exists, suggesting
that translation of the main CDS would occur solely via
the non-AUG initiation site. Considering the large
number of out-of-frame AUGs following the conserved
CUG (in near perfect Kozak context) and the next
in-frame AUG, and the variable position of the AUG, it
seems very likely that the CUG codon is the sole position
at which translation of this CDS is initiated in most or all
mammals.
Ufm1-speciﬁc peptidase 1 (UFSP1) is responsible for
release of the ubiquitin-like protein Ufm1 from
Ufm1-conjugated cellular proteins as well as for activating
the Ufm1 precursor (65). UFSP1 is a cysteine protease in
which Cys53 (numbering relative to the mouse sequence)
is part of the catalytic center and is believed to carry out
the nucleophilic attack on the carbonyl carbon of the sub-
strate (66). UFSP1 is a single-exon gene in mammals.
Unlike the gene in Mus musculus and three other species,
the other 16 available mammalian sequences do not
appear to have in-frame AUG codons capable of initiating
translation of the full-length protein. The ﬁrst available
in-frame AUG is located at a position equivalent to
Met85 of the mouse sequence—i.e. more than 30
residues downstream of the critical Cys53. This means
that, even if UFSP1 initiated with Met85 has some bio-
logical activity, it would be predicted to be non-functional
as a cysteine protease. In fact because of this the human
ortholog is currently designated as ‘non-functional’
although our analysis suggests that initiation at a CUG
codon (in a good Kozak context and in a position nearly
identical to Met1 of mouse Ufsp1) would produce a fully
functional enzyme.
Figure 7. Plots showing density of mRNA fragments protected by
ribosomes for NM_004494 and NM_001010858. The position of the
annotated AUG codon was taken as zero; relative coordinates of
stop codons and predicted non-AUG initiators are indicated. Regions
corresponding to annotated CDSs are highlighted in dark grey; regions
corresponding to non-AUG-initiated extensions are highlighted in light
grey. The presence of ribosomal footprints in the region of an extension
indicates that the initiation of translation takes place upstream of the
annotated CDS.
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In this study, we identiﬁed 42 novel candidates for
conserved non-AUG-initiated N-terminal extensions in
RefSeq human mRNAs. The purpose of this study was
to ﬁnd the most reliable candidates for non-AUG initi-
ation and the approach used was highly conservative.
Therefore, a large number of ﬁlters were used to
increase selectivity at the expense of decreased sensitivity.
First, the initial pool of data were limited only to those
human mRNAs that derive from genes with detectable
homologs in mouse. This limitation was needed to
ensure sufﬁcient depth of phylogenetic analysis required
for MLOGD and Ka/Ks calculations. Therefore all in-
stances of non-AUG initiation utilization in human
genes with no orthologs in mouse would be missed by
this study. The second limitation was the length of
P5EC. All sequences with in-frame stop codons closer
than 50 codons to the annotated CDS start site were
removed by our pipeline. In addition, all sequences that
do not produce an ungapped alignment of mouse-human
P5ECs of at least 25 codons in length were removed. The
minimal alignment length was set to ensure a sufﬁcient
number of substitutions for Ka/Ks estimation. Therefore
it is likely that we missed some cases where a non-AUG
initiator is located close to the annotated CDS start. In
other cases, alternative splicing or alternative transcrip-
tion initiation sites create mRNA species that are
missing the ﬁrst annotated AUG codon. It is conceivable
that some of these transcripts could be translated from a
non-AUG codon prior to the next available in-frame
AUG. Our search deliberately excluded these potential
cases. The currently available RefSeq sequences are
often missing signiﬁcant portions of the 50-terminal
regions of the corresponding mRNAs. This became
evident during our manual analysis of the 742 automatic-
ally selected candidates. In fact, in one case of a candidate
that made it among the 42 ﬁnalists (NM_025160, version
from 26 June 2007), the originally aligned sequence did
have an upstream in-frame AUG codon. However, after
the analysis of available ESTs for the locus we built a gene
model with an extended 50-end beyond this AUG that
itself turned out to have a conserved non-AUG-initiated
extension. The extension appeared to have a candidate
non-AUG start, and the protein sequence generated by
conceptual translation starting from this non-AUG
codon is phylogenetically conserved. In this context, it
should be noted that it is conceivable that the extensions
of some of the candidates identiﬁed here are after all
initiated by AUG codons resulting from rare transcript
variants for which there is currently no evidence in
existing EST databases. Another recently identiﬁed case
of non-AUG initiation [CUG in thioredoxin reductase 3,
TXNRD3 (67)] escaped our analysis for a similar
reason—the corresponding Refseq entry XM_001130163
lacks the 50 region where the CUG codon is situated.
Cases of N-terminal extensions under positive selection
would also have been missed. Finally, only extensions
that can be traced near the root of the mammalian tree
were scored as candidates in our analysis but it is likely
that smaller phylogenetic branches also have conserved
and physiologically active non-AUG-initiated extensions.
For example our analysis indicates that the known
non-AUG extension of CDKN2B is conserved in
primates but not in more distantly related mammals.
For these and probably other reasons the cases of physio-
logically important non-AUG initiation are likely to be
more numerous than those identiﬁed in the current and
previous studies. Furthermore, there could be
non-AUG-initiated coding regions in the 50-UTRs of
mRNAs that are in a different reading frame or separated
by a stop codon from the main CDS. Examples include a
uORF that regulates expression of AZIN1 in vertebrates
(30), and others found by ‘wet’ proteomics analysis (68).
Such cases of non-AUG initiation would have been com-
pletely undetected by our search. Despite all these limita-
tions, our analysis suggests the existence of at least 59
human genes,  0.3% of the total, with conserved
non-AUG-initiated N-terminal extensions.
Previous examples of non-AUG initiation were almost
always found serendipitously after experimental data
showed mismatches between expected and observed
protein masses or sequences. As our analysis has shown,
often such additional protein products were treated as
artifacts or simply ignored because identiﬁcation of their
nature was a problem remote from the primary goals of
these studies. This study has addressed the issue system-
atically by employing the power of comparative genomics
to predict completely overlooked conserved potential
N-terminal extensions.
A very exciting possible reason for utilization of
non-AUG initiation is alternative regulation of initiation
at AUG and non-AUG start codons. Eukaryotes have
developed elaborate mechanisms for recognition of the
correct initiation codon. Mutations are known that
reduce the ﬁdelity of initiation in eukaryotes—speciﬁcally
the ‘Sui
-’ mutants in Saccharomyces cerevisiae (69–70).
Many of these mutations occur in SUI1, also known as
eukaryotic initiation factor 1 (eIF1). Within the ribosomal
machinery ensuring ﬁdelity of initiation in eukaryotes,
eIF1 seems to play a central role (13,71). eIF1 has been
implicated in all three proofreading processes during ini-
tiation: discrimination between AUG and non-AUG
codons; discrimination between AUG codons in good
and poor (Kozak) context and discrimination between
AUG codons close (<20 nts) to the 50 cap and AUG
codons that are further away from the 50 cap (the latter
being preferred for initiation in eukaryotes). eIF1 appears
to confer conformational changes to the scanning 40S
ribosome (72). When bound to it, eIF1 induces an open
conformation conducive to scanning (13). Upon eIF1
release, the 40S subunit is believed to take a closed con-
formation that precludes further scanning and promotes
initiation of translation. If non-AUG initiation is widely
used for regulation, it seems likely that eIF1 plays a major
role in the mechanism. Remarkably, eIF1 in most eukary-
otes appears to be under translation autoregulation
utilizing its ability to inhibit initiation at poor start sites
(32). In this case, an AUG codon in a poor context is used
instead of non-AUG initiation, but experiments in the
same study demonstrated that the amplitude of repression
associated with high levels of eIF1 is even more
4232 Nucleic Acids Research, 2011,Vol.39, No. 10pronounced at non-AUG start codons. Although the ex-
istence of a translational regulation mechanism that
exploits variability in the stringency of start codon selec-
tion is now proven, little is known about the extent of its
utilization in humans. Tripling the number of known
conserved human non-AUG initiation sites would certain-
ly aid in addressing this issue.
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